Quit Intentions Moderate Subjective and Physiological Responses to Acute Nicotine Replacement Therapy Administration in Dependent Smokers

被引:5
|
作者
Schlagintweit, Hera E. [1 ]
Campbell, Niamh K. [1 ]
Barrett, Sean P. [1 ,2 ]
机构
[1] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS B3H 4R2, Canada
[2] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
DENICOTINIZED TOBACCO; SMOKING; INSTRUCTIONS; PHARMACOLOGY; OPPORTUNITY; REACTIVITY; IMPACT; CUES;
D O I
10.1093/ntr/ntw307
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: This study assessed the impact of expectancy and administration components of acute nicotine inhaler use on craving, heart rate, and smoking behavior in smokers with varying intentions to quit. Methods: 47 dependent smokers that differed in self-reported intention to quit (no intention to quit during the next month N = 26 vs. intention to initiate a quit attempt within 2 weeks N = 21) were randomly administered a 4 mg nicotine or nicotine-free inhaler across two sessions. Instructions regarding the inhaler's nicotine content (expect nicotine vs. expect nicotine-free; nicotine expectancy) and flavor (mint vs. citrus) varied across sessions. Craving and heart rate were assessed before and after inhaler administration (two-second inhalations every 10 seconds over 20 minutes). Next, participants were offered an opportunity to self-administer puffs of their preferred tobacco brand during an hour-long progressive ratio task. Results: Across participants, nicotine expectancy independently reduced withdrawal related craving (p = .018), but no comparable effects of nicotine administration were evident. In quitting motivated smokers, nicotine expectancy and administration interacted to reduce intention to smoke (p = .040), while nicotine expectancy (p = .047) and administration (p = .025) independently reduced intention to smoke in quitting unmotivated smokers. Blunted heart rate reactivity to nicotine administration was observed in quitting motivated relative to unmotivated smokers (p = .042); however, neither expectancy nor administration impacted smoking behavior in either group (p values > .25). Conclusions: Findings indicate that participant quitting intentions moderate acute nicotine replacement therapy responses. In quitting motivated smokers, a combination of pharmacological and psychological factors may be necessary for nicotine replacement therapy to impact craving. Implications: Findings from this study demonstrate that motivations to quit smoking moderate subjective and physiological responses to acute nicotine administration and expectancy in dependent cigarette smokers. Quitting motivated smokers showed blunted heart rate reactivity to nicotine administration, suggesting that they may be less sensitive to the rewarding aspects of nicotine consumption. Nicotine administration and expectancy were found to interact to reduce craving in quitting motivated but not in unmotivated smokers, suggesting that pharmacological and psychological factors may be necessary for nicotine replacement therapy to impact craving in smokers who plan to quit.
引用
收藏
页码:922 / 929
页数:8
相关论文
共 46 条
  • [21] Nicotine Replacement Therapy for Smokers with Acute Aneurysmal Subarachnoid Hemorrhage: An International Survey
    Christian V. Eisenring
    Preci L. Hamilton
    Philippe Herzog
    Markus F. Oertel
    Isabelle Jacot-Sadowski
    Felice Burn
    Jacques Cornuz
    Bawarjan Schatlo
    David Nanchen
    [J]. Advances in Therapy, 2022, 39 : 5244 - 5258
  • [22] Nicotine Replacement Therapy is Safe in Smokers Hospitalized With Acute Coronary Heart Disease
    Pack, Quinn R.
    Priya, Aruna R.
    Lagu, Tarau
    Pekow, Penelope S.
    Atreya, Auras R.
    Rigotti, Nancy A.
    Lindenauer, Peter K.
    [J]. CIRCULATION, 2017, 136
  • [23] A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking
    Chan, Sophia S. C.
    Leung, Doris Y. P.
    Abdullah, Abu S. M.
    Wong, Vivian T.
    Hedley, Anthony J.
    Lam, Tai-Hing
    [J]. ADDICTION, 2011, 106 (06) : 1155 - 1163
  • [24] Acute psychomotor, subjective and physiological responses to smoking in depressed outpatient smokers and matched controls
    Malpass, Debra
    Higgs, Suzanne
    [J]. PSYCHOPHARMACOLOGY, 2007, 190 (03) : 363 - 372
  • [25] Acute psychomotor, subjective and physiological responses to smoking in depressed outpatient smokers and matched controls
    Debra Malpass
    Suzanne Higgs
    [J]. Psychopharmacology, 2007, 190 : 363 - 372
  • [26] Effect of the Nicotine Replacement Therapy on Biomarkers of Inflammation, Endothelial Dysfunction, Oxidative Stress, and Lipids in Smokers Who Quit Smoking
    Colsoul, Marie-Lise
    Goderniaux, Nicolas
    Onorati, Sabrina
    Dupuis, Stephanie
    Jamart, Jacques
    Vanpee, Dominique
    Berlin, Ivan
    Galanti, Laurence
    [J]. NICOTINE & TOBACCO RESEARCH, 2023, 25 (12) : 1875 - 1881
  • [27] Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit
    Carpenter, MJ
    Hughes, JR
    Solomon, LJ
    Callas, PW
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2004, 72 (03) : 371 - 381
  • [28] Abrupt versus gradual smoking cessation with pre-cessation nicotine replacement therapy for cigarette smokers motivated to quit
    Klemperer, Elias M.
    Fagerstrom, Karl O.
    Hughes, John R.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (19)
  • [29] Racial/ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years
    Fu, Steven S.
    Kodl, Molly M.
    Joseph, Anne M.
    Hatsukami, Dorothy K.
    Johnson, Eric O.
    Breslau, Naomi
    Wu, Baolin
    Bierut, Laura
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (07) : 1640 - 1647
  • [30] Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy
    Lawson, GM
    Hurt, RD
    Dale, LC
    Offord, KP
    Croghan, IT
    Schroeder, DR
    Jiang, NS
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (06): : 510 - 516